Latest: Recent quarterly results (late January) showed ~15–16% YoY profit growth and dividend declarations; on 12 Feb the stock showed mild consolidation. What it means: Pharma with diversified geographic sales and branded business can show steady cash flows. Beginner takeaway: Pharma can be defensive but watch product approvals, pricing and regulatory news. Risk: Generic pricing pressure, litigation or regulatory action. Action: If you like pharma for stability, prefer companies with strong R&D pipeline & branded revenue.

#WatchOutFor#PersonalFinance#FundamentalViews

595 likes·65 comments